Navigation Links
InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
Date:9/16/2008

Morhet, Chairman and Chief Executive Officer. "I'm pleased with our scientific progress, regulatory plans and soon we'll be well positioned to begin formal discussions with the FDA."

About DXL(TM) Technology Platform

DXL(TM) technology works by integrating self-binding peptides into monoclonal antibodies, potentiating target binding. Modified antibodies "cluster" upon engaging the target receptor site, resulting in greater "molecular mass" at the point of association. DXL(TM) antibodies have significantly extended dissociation rates, as measured by surface plasmon resonance. As a consequence, this may facilitate cancer cell destruction in a target dependent manner by increasing apoptosis, antibody dependent cell cytotoxicity and complement-dependent cytotoxicity. To learn more about InNexus' DXL(TM) technology, please visit http://www.ixsbio.com.

About InNexus

InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL(TM) technology, which improves the potency of new and existing antibody products while opening new markets and disease applications. DXL(TM) antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in- house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit http://www.ixsbio.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. This news release may contain assumptions, estimates, and other forward-looking statements
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
7. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
8. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
9. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 28, 2014 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... Securities Purchase Agreement with Deerfield Management and certain ... will issue shares of preferred stock to Deerfield ... million upon the satisfaction of certain closing conditions. ...
(Date:11/28/2014)... HK$,000Six months endedChange %  30 September 201430 September 2013Turnover 546,011 , ... , 384,242 , 339,113 , 13.3 ... 41,377 , 49.5 Medical Insurance Administration Service Income ... Medical Devices and Accessories Sales , 94,580 , ... 2,917 , 9,219 , (68.4) Impairment Loss ...
(Date:11/27/2014)... November 27, 2014 Hovione announced ... (IND) Application with the U.S. Food and Drug Administration ... of developing improved drug delivery options for established drugs. ... a novel formulation using a new patented crystalline base ... most widely prescribed oral antibiotics for acne. Currently, there ...
Breaking Medicine Technology:Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Hovione Files its First Investigational New Drug Application With the FDA 2
... Biotica Technology,Limited, a privately-held biotechnology company, announces ... to discover, develop,and commercialise novel erythromycin-based macrolides ... In a three year research collaboration, Biotica ... that are not readily,accessible via conventional medicinal ...
... 9 Anesiva, Inc.,(Nasdaq: ANSV ) ... Administration,(FDA) has approved Anesiva,s supplemental New Drug Application ... the pain associated with blood,draws to include adults. ... previously approved to treat the pain,associated with peripheral ...
Cached Medicine Technology:Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline 2Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication 2
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Not only ... create products free of petroleum, parabens and other cancer-causing ... that fund research, education and awareness programs that help ... staff and owners have raised an incredible, record-breaking contribution ... the Cure, sales of the Sweet Red Rose Whip ...
(Date:11/28/2014)... Hamilton, ON Canada (PRWEB) November 28, 2014 ... labels for the stuff kids lose® and an award-winning ... Julie Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby ... Entrepreneur Award. They were recognized with the PROFIT Award ... Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby) accepted ...
(Date:11/28/2014)... Lice Troopers Lice Removal Service is pleased to ... lice service for moms in Miami-Dade County. Lice Troopers is ... on Pone De-leon Blvd in Miami. The company currently ... Miami-Dade & Broward. Lice Troopers is the only Lice Clinic ... been treating families for several years. , Lice Troopers estimate ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic ... equipment to its students. That is why the ... play structure at its mental health services facility ... programs for children who are identified as needing ... have served the needs of children with severe ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
... , NEW YORK, July 21 BET News correspondent, Andre ... Obama,s news conference in Washington on Wednesday, July 22 ( ... BET J will re-air an encore broadcast of the entire news conference ... Sophia Nelson at 10:00 p.m. The President is expected ...
... KALAMAZOO, Mich., July 21 Stryker Corporation (NYSE: SYK ) reported ... , Second Quarter Highlights , ... million were flat (0.1% decrease) on a constant currency basis (4.6% decrease as ... constant currency basis (0.2% decrease as reported) , MedSurg ...
... , , ALISO VIEJO, Calif., July 21 ... it will host a conference call and a live Internet webcast along ... EDT (7:00 a.m. PDT) to discuss results for the 2009 second quarter. ... on this call is (877) 295-5743, confirmation code 20797641. International callers ...
... MEQUON, Wis., July 21 Wonderbox Technologies has released version ... from continued advances in technology and software features. Central to ... managed care benefit administration and case management. The Care Management ... and monitoring day-to-day care tasks and case assignments. , ...
... , , NEW YORK, July ... action against MetLife. The class action involves MetLife,s April 2000 conversion ... class action certified by the Federal Court in New York includes ... , The notice of the class action ...
... on how they help arteries stay clear and healthy , ... technology, researchers have begun to discover the exact molecular reasons ... -- and ordinary orange juice are good for the health ... reporting studies describing the range of genes that are affected ...
Cached Medicine News:Health News:BET Networks Airs Special Coverage of President Obama's News Conference on Health Care 2Health News:Stryker Operating Results for Quarter Ended June 30, 2009 2Health News:Stryker Operating Results for Quarter Ended June 30, 2009 3Health News:Stryker Operating Results for Quarter Ended June 30, 2009 4Health News:Stryker Operating Results for Quarter Ended June 30, 2009 5Health News:Stryker Operating Results for Quarter Ended June 30, 2009 6Health News:Stryker Operating Results for Quarter Ended June 30, 2009 7Health News:Stryker Operating Results for Quarter Ended June 30, 2009 8Health News:Stryker Operating Results for Quarter Ended June 30, 2009 9Health News:Stryker Operating Results for Quarter Ended June 30, 2009 10Health News:Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009 2Health News:Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System 2Health News:Notice Begins Announcing Pendency of a Class Action Regarding MetLife 2Health News:Notice Begins Announcing Pendency of a Class Action Regarding MetLife 3Health News:Studies Show Genetic Activity of Antioxidants 2Health News:Studies Show Genetic Activity of Antioxidants 3
... BioCheck FSH EIA Test is ... a solid phase enzyme-linked immunosorbent ... mouse monoclonal anti-FSH for solid ... sheep anti-alpha FSH in the ...
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... glygoprotein produced by the anterior pituitary gland. Like ... FSH consists of subunits designated as alpha and ... sandwich ELISA method. The samples and diluted anti-FSH-HRP ... Mab to FSH beta subunit. FSH in the ...
... is a glycoprotein hormone secreted by ... LH and TSH, the intact FSH ... of alpha- and beta-subunits. Its production ... hormone (GnRH) from the hypothalamus. GnRH ...
Medicine Products: